RIV:CC News and Press, Riv Capital Inc. Class A Common Shares

RIV Capital Strengthens Senior Leadership Team Ahead of Anticipated Transformational Merger with Cansortium Inc. Canada NewsWire Appoints Experienced New York and California Cannabis Executive, David Vautrin as Chief Retail Officer to Lead Retail Platform ...

MARYSVILLE, Ohio, May 30, 2024 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG) announced its support for the planned combination of RIV Capital and Cansortium, stating the move will enhance its strategic stake in cannabis cultivation and retail operations in important high-growth s...

Canadian Investment Regulatory Organization Trade Resumption - RIV Canada NewsWire VANCOUVER, BC , May 30, 2024 /CNW/ - Trading resumes in: Company: RIV Capital Inc. CSE Symbol: RIV All Issues: Yes Resumption (ET): 10:45 AM CIRO can make a dec...

RIV Capital Reports Financial Results for the First Quarter Ended March 31, 2024 Canada NewsWire Successfully opened first adult-use dispensary in White Plains, New York Ended the quarter with $65.9 million of cash to support growth strategy in New York and...

Combined Company’s footprint will provide access to Florida, New York, Texas, and Pennsylvania, with significant growth potential and future regulatory catalysts in all four states Combined Company expected to leverage Cansortium’s robust operating expertise as well as RIV...

Canadian Investment Regulatory Organization Trading Halt - RIV Canada NewsWire VANCOUVER, BC , May 30, 2024 /CNW/ - The following issues have been halted by CIRO: Company: RIV Capital Inc. CSE Symbol: RIV All Issues: Yes Reason: Pending News Halt ...

RIV Capital Applauds Reports that DEA Plans to Reschedule Cannabis Canada NewsWire TORONTO , May 1, 2024 /CNW/ - RIV Capital Inc. ("RIV Capital" or the "Company") (CSE: RIV) (OTC: CNPOF), an acquisition and investment firm with a focus on building a leading multi...

RIV Capital Reports Financial Results for the Fiscal Quarter and Nine-Month Transition Period Ended December 31, 2023 PR Newswire Etain received New York Cannabis Control Board approval to commence adult-use operations in New York Ended the year with $81.9 millio...

RIV Capital Sets Date for Financial Results for the Fiscal Quarter and Nine-Month Transition Year Ended December 31, 2023 Canada NewsWire TORONTO , April 22, 2024 /CNW/ - RIV Capital Inc. (" RIV Capital " or the " Company ") (CSE: RIV) (OTC: CNP...

Helix BioPharma Corp. (HBP:CA) is expected to report for Q2 2024 RIV Capital Inc. Class A common shares (RIV:CNX) is expected to report for quarter end 2023-12-31 Medicus Pharma Ltd. (MDCX:CA) is expected to report for Q4 2023 Highwood Asset Management Ltd. (HAM:CA) is expected to rep...